Abraham Chesed files SEC Form 4 disclosures for Turn Therapeutics Inc.. They have made 1 open-market trade across 1 company since 2025, most recently 2025-10-23.
CIK 0002094374
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $131K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TTRX | 1,447,268 | $15.3M |
Shares reported on the most recent Form 4, priced at the 2025-10-29 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TTRX | BUY | 2025-10-23 | 2025-10-29 | $4.60 | $131K | -22.8% | -34.2% | -7.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.